RE-BVS – Piemonte Repository

Sfoglia per AUTORE
TERRAGNA C
Collezione AOU Città della Salute di Torino

Items : 5

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment? in Frontiers in oncology / Front Oncol. 2023 Jul 31;13:1247808. doi: 10.3389/fonc.2023.1247808. eCollection 2023.

2023
AOU Città della Salute di Torino

Terragna C; van Duin M; D'Agostino M;

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience. in American journal of hematology / Am J Hematol. 2021 Oct 1;96(10):1204-1210. doi: 10.1002/ajh.26287. Epub 2021 Jul 23.

2021
AOU Città della Salute di Torino

Carella M; Lolli G; Morigi A; Casadei B; Pellegrini C; Stefoni V; Gabrielli G; Sabattini E; Terragna C; Nanni L; Argnani L; Broccoli A; Coppola PE; Zinzani PL;

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial. in Journal of hematology & oncology / J Hematol Oncol. 2019 Jan 9;12(1):4. doi: 10.1186/s13045-018-0691-4.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ria R; Boccadoro M; Vacca A; Dammacco F; Petrucci MT; Musto P; Montefusco V; Rizzo M; Falcone AP; Grasso M; Gottardi D; Leonardi G; Baldini L; Benevolo G; Callea V; Patriarca F; Guglielmelli T; Nozzoli C; Larocca A; Offidani M; De Paoli L; Martino E; Bringhen S; Palumbo A; Omedè P; Giuliani N; Saltarella I; Terragna C; Morabito F; et alii...

The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD). in Oncotarget / Oncotarget. 2016 Mar 1;7(9):9666-79. doi: 10.18632/oncotarget.5718.

2016
AOU Città della Salute di Torino

Terragna C; Remondini D; Martello M; Zamagni E; Pantani L; Patriarca F; Pezzi A; Levi G; Offidani M; Proserpio I; De Sabbata G; Tacchetti P; Cangialosi C; Ciambelli F; Viganò CV; Dico FA; Santacroce B; Borsi E; Brioli A; Marzocchi G; Castellani G; Martinelli G; Palumbo A; Cavo M;

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival. in Leukemia / Leukemia. 2015 Mar;29(3):689-95. doi: 10.1038/leu.2014.219. Epub 2014 Jul 16.

2015
AOU Città della Salute di Torino

Terragna C; Musto P; Oliva S; Pisani F; Falcone AP; Pregno P; Crippa C; De Rosa L; Callea V; Carovita T; Liberati AM; Cangialosi C; Guglielmelli T; Rossini F; Grasso M; Caltagirone S; Urbano M; Genuardi E; Cavallo F; Ladetto M; Drandi D; Ferrero S; Passera R; Boccadoro M; Palumbo A;